Chelating ligands for nanocrystals' surface functionalizationQUERNER, Claudia; REISS, Peter; BLEUSE, Joël et al.Journal of the American Chemical Society. 2004, Vol 126, Num 37, pp 11574-11582, issn 0002-7863, 9 p.Article

Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 RecoveryENGSIG, Frederik N; ZANGERLE, Robert; GUTIERREZ, Félix et al.Clinical infectious diseases. 2014, Vol 58, Num 9, pp 1312-1321, issn 1058-4838, 10 p.Article

Bone Mineral Density Increases in HIV-Infected Children Treated With Long-term Combination Antiretroviral TherapyBUNDERS, Madeleine J; FRINKING, Olivier; SCHERPBIER, Henriette J et al.Clinical infectious diseases. 2013, Vol 56, Num 4, pp 583-586, issn 1058-4838, 4 p.Article

Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor― induced severe hyperlactataemia in HIV―infected adults: an exploratory studyARENAS-PINTO, Alejandro; WELLER, Ian; INGRAM, Catherine et al.Antiviral therapy (London). 2012, Vol 17, Num 2, pp 275-282, issn 1359-6535, 8 p.Article

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patientsPETERS, Lars; GRINT, Daniel; LUNDGREN, Jens D et al.AIDS (London). 2012, Vol 26, Num 15, pp 1917-1926, issn 0269-9370, 10 p.Article

Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNAFEENEY, Eoin R; VONDEREN, Marit G. A. Van; WIT, Ferdinand et al.AIDS (London). 2012, Vol 26, Num 17, pp 2165-2174, issn 0269-9370, 10 p.Article

Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral TherapyKESSELRING, Anouk; GRAS, Luuk; SMIT, Colette et al.Clinical infectious diseases. 2011, Vol 52, Num 12, pp 1458-1465, issn 1058-4838, 8 p.Article

Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral TherapyWORODRIA, William; MASSINGA-LOEMBE, Marguerite; COLEBUNDERS, Robert et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 32-37, issn 1525-4135, 6 p.Article

A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophyBLÜMER, Regje M. E; VAN DER VALK, Marc; ACKERMANS, Mariette et al.American journal of physiology. Endocrinology and metabolism. 2009, Vol 60, Num 5, pp 1097-1104, issn 0193-1849, 8 p.Article

First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/ lopinavir/ritonavirVAN VONDEREN, Marit G. A; LIPS, Paul; VAN AGTMAEL, Michiel A et al.AIDS (London). 2009, Vol 23, Num 11, pp 1367-1376, issn 0269-9370, 10 p.Article

Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic SuppressionPETERS, Lars; MOCROFT, Amanda; SORIANO, Vincent et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 5, pp 457-463, issn 1525-4135, 7 p.Article

Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production : National Cholesterol Awareness MonthFRANSSEN, Remco; SANKATSING, Raaj R; SAUERWEIN, Hans P et al.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 9, pp 1336-1341, issn 1079-5642, 6 p.Article

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapyKESSELRING, Anouk M; WIT, Ferdinand W; MOCROFT, Amanda et al.AIDS (London). 2009, Vol 23, Num 13, pp 1689-1699, issn 0269-9370, 11 p.Article

Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyBLÜMER, Regje M. E; VAN VONDEREN, Marit G. A; SUTINEN, Jussi et al.AIDS (London). 2008, Vol 22, Num 2, pp 227-236, issn 0269-9370, 10 p.Article

Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissueDEN BOER, Marion A. M; BERBEE, Jimmy F. P; REISS, Peter et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 1, pp 124-129, issn 1079-5642, 6 p.Article

Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapyCASULA, Miriam; WEVERLING, Gerrit Jan; WIT, Ferdinand W et al.The Journal of infectious diseases. 2005, Vol 192, Num 10, pp 1794-1800, issn 0022-1899, 7 p.Article

Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in hiv-1-infected patients randomly allocated to zidovudine- or stavudine-based therapyVAN DER VALK, Marc; CASULA, Miriam; DE RONDE, Anthony et al.Antiviral therapy (London). 2004, Vol 9, Num 3, pp 385-393, issn 1359-6535, 9 p.Article

Is the male genital tract really a sanctuary site for HIV? Arguments that it is notLOWE, Selwyn H; SANKATSING, Sanjay U. C; REPPING, Sjoerd et al.AIDS (London). 2004, Vol 18, Num 10, pp 1353-1362, issn 0269-9370, 10 p.Article

Mortality and progression to AIDS after starting highly active antiretroviral therapy. CommentaryVAN SIGHEM, Ard I; VAN DE WIEL, Mark A; GHANI, Azra C et al.AIDS (London). 2003, Vol 17, Num 15, pp 2227-2236, issn 0269-9370, 12 p.Article

Once-daily indinavir plus ritonavir : preliminary results of the PIPO studyBURGER, David M; HUGEN, Patricia W. H; VAN DER ENDE, Marchina E et al.AIDS (London). 2000, Vol 14, Num 16, pp 2621-2623, issn 0269-9370Article

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaborationSMITH, Colette J; RYOM, Lene; KIRK, Ole et al.Lancet (British edition). 2014, Vol 384, Num 9939, pp 241-248, issn 0140-6736, 8 p.Article

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGE_hIV Cohort StudySCHOUTEN, Judith; WIT, Ferdinand W; STOLTE, Ineke G et al.Clinical infectious diseases. 2014, Vol 59, Num 12, pp 1787-1797, issn 1058-4838, 11 p.Article

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease eventsD'ARMINIO MONFORTE, Antonella; REISS, Peter; PRADIER, Christian et al.AIDS (London). 2013, Vol 27, Num 3, pp 407-415, issn 0269-9370, 9 p.Article

Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE StudyCOTTER, Aoife G; VROUENRAETS, Saskia M. E; BRADY, Jennifer J et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 4, pp 1659-1666, issn 0021-972X, 8 p.Article

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfectionWORODRIA, William; MENTEN, Joris; COLEBUNDERS, Robert et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 841-848, issn 1359-6535, 8 p.Article